LFWD (ReWalk Robotics Ltd) Market Value to Book Value Ratio

ReWalk Robotics Ltd (LFWD) - corporate logo

ReWalk Robotics Ltd. generates revenue through the sale of innovative exoskeletons designed to restore patients' motor functions. The price-to-book value ratio trend on the GURU.Markets terminal linear chart clearly demonstrates the relationship between market value and assets, where the 1.36 indicator expresses the state of the metric. Strong medical confidence in the brand and efficient insurance reimbursement systems in developed countries ensure the company's sustainable leadership within the niche.

Market Capitalization to Net Assets: Lifeward Ltd. (LFWD) for 02/21/2024 - 10/27/2026
Finished products of ReWalk Robotics

Portfolio managers are closely examining the operating model of ReWalk Robotics Ltd. (LFWD) as a leader in the medical exoskeleton segment. This multiple compares the market value of shares with the amount of net assets, identifying whether the business is overvalued or undervalued. By analyzing the current market-to-book value ratio, investors determine the degree of discount relative to real capital. For this pioneer of home rehabilitation, this balance reflects market confidence in the capitalization of unique technologies. The stability of this metric confirms the fundamental resilience of the company.

Direct competitors

Market Capitalization to Book Value Ratio Boston Scientific|EW (edwards.com) - Capitalization to Book Value Ratio|RMD: Market Value to Book Value Ratio|Market Capitalization to Book Value PODD|ZBH - Market Value to Book Value Ratio|Market Capitalization to Net Assets CooperSurgical (COO)|ALGN: Market Capitalization to Book Value Ratio|Market-to-Book Ratio globusmedical.com GMED|TMDX: Market Capitalization to Book Value Ratio|ATEC - Market Cap to Net Assets Ratio|Artivion Inc - Market Capitalization to Book Value Ratio|Enovis Inc. (ENOV) - Market Capitalization to Book Value|IART (Integra LifeSciences) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio ESTA|Market Value to Book Value Ratio Beta Bionics (BBNX)|Market Value to Book Value Ratio IRADIMED Corp (IRMD)|Market Capitalization to Book Value Ratio EMBC|TNDM - Market Capitalization to Book Value|Market Cap to Net Assets Ratio AxoGen, Inc.|SIBN - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio OFIX|Bioventus Inc (BVS) - Market-to-Book Ratio|Market Capitalization to Book Value Ratio OrthoPediatrics Corp (KIDS)|Capitalization to Book Value Ratio Treace Corp (TMCI)|Strata Critical Medical Inc (SRTA) - Market Cap to Net Assets Ratio|Market Value to Book Value CARL (carlsmed.com)|RxSight - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio ClearPoint Neuro Inc. CLPT|STXS (Stereotaxis Corp) - Market Capitalization to Book Value Ratio|STIM - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Sight Sciences, Inc.|orchestrabiomed.com (OBIO) - Capitalization to Book Value Ratio|ANIK: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value InspireMD Inc|Market Capitalization to Book Value Ratio ZJYL (Jin Medical International)|Market Cap to Net Assets Ratio vivani.com (VANI)|Market Capitalization to Book Value Ratio XTNT (Xtant Medical)|n1mtc.com - Market Capitalization to Book Value Ratio|MODD - Market Value to Book Value Ratio|Myomo Inc. (MYO) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Envoy Medical, Inc COCH|Vivos Therapeutics Inc (VVOS) - Market Value to Book Value|Market Capitalization to Book Value Ratio NVNO (enVVeno Medical)|Market-to-Book Ratio SINT|TNON: Market Value to Book Value Ratio|Market Value to Equity Ratio autonomix.com AMIX|Market Cap to Net Assets Ratio IVF (INVO Bioscience, Inc.)|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Market Capitalization to Book Value Ratio AXNX (Axonics, Inc.)|BIOL: Market Capitalization to Book Value|Market Value to Book Value Ratio dynatronics.com (DYNT)|FNA (Paragon 28) - Market Capitalization to Net Assets|Market Value to Book Value Ratio INVO